Antiandrogenic activity and bioavailability of magnolol analogs – A potential for prostate cancer therapeutics

Antiandrogenic activity and bioavailability of magnolol analogs – A potential for prostate cancer therapeutics

Background: Prostate cancer is the second most common form of cancer in men worldwide and there is a great need for novel treatment strategies, especially for castrate-resistant prostate cancers where the proliferation of the cancer cells is stimulated by androgens produced in the adrenal cortex and...

Full description

Bibliographic Details
Main Authors: Agneta Oskarsson, Geeta Mandava, Corrado Tringali, Luana Pulvirenti, Vera Muccilli, Johan Lundqvist
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Phytomedicine Plus
Subjects:
Magnolol
Prostate
Cancer
Antiandrogenic
Online Access:http://www.sciencedirect.com/science/article/pii/S2667031323000817

Similar Items

Similar Items